Correction to: Acta Pharmacologica Sinica https://doi.org/10.1038/s41401-021-00853-8, published online 07 February 2022
Western blot images of p-AKT and AKT in Fig. 8c and 8d were inadvertently misplaced in the process of assembling figures. The correct versions are shown. The corrigendum does not affect the conclusion. The authors apologize for any inconvenience this may have caused. The original article has been corrected.
Corrected:
c, d BV-2 cells were pretreated for 5 min with U0126 (20 μM) and then stimulated for 30 min with either 2-AG (10 μM) or JWH015 (10 μM). Whole-cell lysates were prepared and immunoblotted as described in Materials and Methods with antibodies that recognize p-AKT (Ser473) and total AKT. The densitometric data represent the means ± SD of two independent experiments performed in triplicate. *P < 0.05, **P < 0.01 vs control group. ###P < 0.001 vs 2-AG or JWH015 treated-group.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Han, Qw., Shao, Qh., Wang, Xt. et al. Author Correction: CB2 receptor activation inhibits the phagocytic function of microglia through activating ERK/AKT-Nurr1 signal pathways. Acta Pharmacol Sin 45, 2228 (2024). https://doi.org/10.1038/s41401-024-01337-1
Published:
Issue date:
DOI: https://doi.org/10.1038/s41401-024-01337-1